Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials
Main Authors: | Chenyue Zhang, Haiyong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-021-00557-9 |
Similar Items
-
Therapeutic approaches and development of genomic diagnostic tools for Usher syndrome
by: Fuster García, Carla
Published: (2020) -
Usher syndrome: clinical features, molecular genetics and advancing therapeutics
by: Maria Toms, et al.
Published: (2020-09-01) -
The Era of Precision Medicine: Reshaping Usher Syndrome
by: Jinsei Jung
Published: (2020-05-01) -
Síndrome de Usher: características clínicas Usher's syndrome: clinical characteristics
by: Josilene de Carvalho Soares Liarth, et al.
Published: (2002-08-01) -
Ushering in a new era of RNA-based therapies
by: Robert DeLong
Published: (2021-05-01)